Task A10 - test candidate therapeutics against papillomaviruses in mouse and rabbit models, with the mouse model representing a screening model for the more advanced studies to be conducted in the…
Active Awarded Last action
- Contract number
- 75N93025F00001
- Awardee
-
Pennsylvania State University UEI TNKGNDAWB445
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $311,680
Award facts
- Opportunity
-
- A10 Solicitation number
- Contract value 25% obligated
-
- $311,680.00 Current, with exercised options
- $1,232,512.00 Potential, with all options
- Completion date 75% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Hershey, PA 17033, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $311,680 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) on September 22, 2025, with a ceiling value of $1,232,512 under the Pre-Clinical Models of Infectious Diseases IDIQ.
The order funds testing of candidate therapeutics against papillomaviruses using mouse and rabbit models, with the mouse model serving as a screening tool for advanced studies in the rabbit model. Toxicological studies are included. Work is performed at Penn State Hershey Medical Center in Hershey, PA, with an ultimate completion date of February 28, 2027. The order is priced on a cost-no-fee basis with no set-aside applied.
Description
Task A10 - test candidate therapeutics against papillomaviruses in mouse and rabbit models, with the mouse model representing a screening model for the more advanced studies to be conducted in the rabbit model. Toxicological studies are conducted to
Quick answers
Who was awarded contract 75N93025F00001?
75N93025F00001 was awarded to Pennsylvania State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 22, 2025.
How much is contract 75N93025F00001 worth?
The government has obligated $311,680 on 75N93025F00001. Its potential value, with all options, is $1,232,512.
Is contract 75N93025F00001 an order under another contract?
Yes. 75N93025F00001 is a delivery order under 75N93024D00024, an indefinite delivery contract, on Pre-Clinical Models of Infectious Diseases.
Was contract 75N93025F00001 competed?
The extent of competition for 75N93025F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award